Background and Objectives. Combinations of bupivacaine and fentanyl ar
e popular for postoperative epidural analgesia. However, there are lit
tle data from which to select a rational dose of bupivacaine. The stud
y examined the effects of increasing amounts of epidural bupivacaine o
n postoperative analgesia, epidural fentanyl consumption, and side eff
ects after thoracotomy. Methods. Twenty-four patients were randomized
in a double-blind manner to receive intra- and postoperative epidural
infusions of either saline, 0.01% bupivacaine, 0.05% bupivacaine, or 0
.1% bupivacaine at 10 mL/h. All patients received a standardized combi
ned epidural (120 mg lidocaine and 1.5 mu g/kg of fentanyl) and genera
l anesthesia. Further postoperative analgesia was provided with fentan
yl patient-controlled epidural analgesia (PCEA) only. Results. There w
ere no differences between groups in visual analog scale (VAS) pain sc
ores at rest or cough, but 10 and 5 mg/h of bupivacaine provided bette
r analgesia during physiotherapy (P <.05). The use of 10 and 5 mg/h of
bupivacaine led to significant opioid sparing (50% decrease) when com
pared to saline and 1 mg/h bupivacaine (P <.03). There was a trend tow
ard a greater incidence of orthostasis with the use of bupivacaine at
10 mg/h (P =.09). Incidences of opioid side effects were not different
between groups. Conclusions. The results demonstrate improved analges
ia with physiotherapy and significant opioid sparing when 10 and 5 mg/
h doses of bupivacaine are used. However, the incidence of orthostasis
may be increased with the use of 10 mg/h. Thus, 5 mg/h of epidural bu
pivacaine (.05% at 10 mL/h) improved anal gesia, decreased opioid requ
irements, and did not have detectable hemodynamic effects.